Skip to main content
Erschienen in: Neurocritical Care 3/2013

01.06.2013 | Original Article

Clinical Outcomes Following Prolonged Refractory Status Epilepticus (PRSE)

verfasst von: R. D. Kilbride, A. S. Reynolds, J. P. Szaflarski, L. J. Hirsch

Erschienen in: Neurocritical Care | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

To define the clinical profile and outcome of patients in prolonged refractory status epilepticus (PRSE), and investigate possible predictors of outcome.

Methods

We reviewed 63 consecutive patients with PRSE cared for in the medical and neurointensive care units of three academic medical centers over a 9-year period. For this multi-center retrospective cohort study, PRSE was defined as SE that persisted despite at least 1 week of induced coma. Variables examined for their relationship to outcome included etiology, EEG, neuroimaging, and age.

Results

Forty-two (66 %) of 63 patients in PRSE survived to discharge from hospitalization. Fourteen (22 %) patients had a good outcome (mRS ≤ 3) at last available follow up (at least 6 months post-PRSE). Of these, 6 (10 %) individuals had no significant disability and were able to carry out all usual activities (mRS = 1). Normal neuroimaging and a reactive EEG at onset of PRSE were associated with good outcome. Good or excellent clinical outcomes were possible in patients in PRSE for up to 79 days, and in patients up to 69 years old.

Conclusions

Good outcome is not unusual in PRSE, including in some older patients, in a variety of diagnoses, and despite months of coma.
Literatur
1.
Zurück zum Zitat Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205–10.PubMedCrossRef Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205–10.PubMedCrossRef
2.
Zurück zum Zitat DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–35.PubMedCrossRef DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–35.PubMedCrossRef
5.
Zurück zum Zitat Drislane FW, Lopez MR, Blum AS, Schomer DL. Survivors and nonsurvivors of very prolonged status epilepticus. Epilepsy Behav. 2011;22(2):342–5.PubMedCrossRef Drislane FW, Lopez MR, Blum AS, Schomer DL. Survivors and nonsurvivors of very prolonged status epilepticus. Epilepsy Behav. 2011;22(2):342–5.PubMedCrossRef
6.
Zurück zum Zitat Bramstedt KA, Morris HH, Tanner A. Now we lay them down to sleep: ethical issues with the use of pharmacologic coma for adult status epilepticus. Epilepsy Behav. 2004;5(5):752–5.PubMedCrossRef Bramstedt KA, Morris HH, Tanner A. Now we lay them down to sleep: ethical issues with the use of pharmacologic coma for adult status epilepticus. Epilepsy Behav. 2004;5(5):752–5.PubMedCrossRef
7.
Zurück zum Zitat van Swieten J, Koudstaal P, Visser M, Schouten H, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–7.PubMedCrossRef van Swieten J, Koudstaal P, Visser M, Schouten H, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–7.PubMedCrossRef
8.
Zurück zum Zitat Young GB, Kreeft JH, McLachlan RS, et al. EEG and clinical associations with mortality in comatose patients in a general intensive care unit. J Clin Neurophysiol. 1999;16:354–60.PubMedCrossRef Young GB, Kreeft JH, McLachlan RS, et al. EEG and clinical associations with mortality in comatose patients in a general intensive care unit. J Clin Neurophysiol. 1999;16:354–60.PubMedCrossRef
9.
Zurück zum Zitat Austin EJ, Wilkus RJ, Longstreth WT Jr. Etiology and prognosis of alpha coma. Neurology. 1988;38:773–7.PubMedCrossRef Austin EJ, Wilkus RJ, Longstreth WT Jr. Etiology and prognosis of alpha coma. Neurology. 1988;38:773–7.PubMedCrossRef
10.
Zurück zum Zitat Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980;69(5):657–66.PubMedCrossRef Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980;69(5):657–66.PubMedCrossRef
11.
Zurück zum Zitat Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord H. A “malignant” variant of status epilepticus. Arch Neurol. 2005;62:1428–31.PubMedCrossRef Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord H. A “malignant” variant of status epilepticus. Arch Neurol. 2005;62:1428–31.PubMedCrossRef
Metadaten
Titel
Clinical Outcomes Following Prolonged Refractory Status Epilepticus (PRSE)
verfasst von
R. D. Kilbride
A. S. Reynolds
J. P. Szaflarski
L. J. Hirsch
Publikationsdatum
01.06.2013
Verlag
Humana Press Inc
Erschienen in
Neurocritical Care / Ausgabe 3/2013
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-013-9823-4

Weitere Artikel der Ausgabe 3/2013

Neurocritical Care 3/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.